Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

Combining Lynparza (olaparib) and Keytruda (pembrolizumab) showed antitumor activity in multiple cancer types, particularly those with BRCA1/2 ...

Dana-Farber Brigham Cancer Center-led phase 3 clinical trial shows that pembrolizumab before and after standard-of-care surgery significantly extends ...

The CR rate was consistent across subgroups including men and women, patients with and without papillary disease, and ...

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...

Marc Dubrick and Grace Alexander claimed hard-fought victories Sunday morning in the 42nd St. Anthony's Triathlon along St.

Antibody-drug conjugates continue to show benefits in breast cancer, plus the FDA has fast-tracked an innovative AI tool to help identify pancreatic tumors.

Hera Women's Health ("Hera"), an Imperial Capital ("Imperial") portfolio company, is pleased to announce the appointment of Dr. Andy Wagner as the company's new Chief Executive Officer (CEO). Wagner ...

Of the 422 patients, 198 (47%) experienced a recurrence following surgery. There was an almost even split between early (34%), mid (33%), and late recurrences (32%). Time to recurrence was associated ...

Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find ...

Men in short leather pants and embroidered suspenders risked dislocated digits as they vied for the top prize at Germany’s championship in the sport of fingerhakeln or finger wrestling. Around ...